Results 71 to 80 of about 101,012 (310)
Update of the CLRP TG-43 parameter database for low-energy brachytherapy sources [PDF]
PURPOSE: To update the Carleton Laboratory for Radiotherapy Physics (CLRP) TG-43 dosimetry database for low-energy (< 50 keV) photon-emitting low-dose rate (LDR) brachytherapy sources utilizing the open-source EGSnrc application egs_brachy rather than the BrachyDose application used previously for 27 LDR sources in the 2008 CLRP version (CLRPv1 ...
arxiv +1 more source
Abstract Background The use of deep learning‐based auto‐contouring algorithms in various treatment planning services is increasingly common. There is a notable deficit of commercially or publicly available models trained on large or diverse datasets containing high‐dose‐rate (HDR) brachytherapy treatment scans, leading to poor performance on images ...
Andrew J. Krupien+8 more
wiley +1 more source
Key points 125I brachytherapy is a treatment for locally recurrent HCC after ablation. 125I brachytherapy combined with ablation may improve tumor control. Vascular invasion, multiple lesions, and AFP are prognostic risk factors.
Wenliang Zhu+7 more
doaj +1 more source
Abstract In radiation oncology, inter‐fractional dosimetry using optically stimulated luminescent detectors (OSLDs) ensures accurate plan delivery and patient safety. RadPro International GmbH's myOLSchip system, featuring a beryllium oxide (BeO) OSL dosimeter, reader, and eraser, was characterized and calibrated with a Varian Truebeam for in‐vivo ...
Heath Davis+3 more
wiley +1 more source
Background To compare the severity of radiation-induced lung injury (RILI) after the right lung of SD rats received interstitial brachytherapy and stereotactic radiotherapy (SBRT).
Zhuo Chen+8 more
doaj +1 more source
Peripheral vascular brachytherapy [PDF]
Ongoing advances in peripheral endovascular technology have been met with disappointing results because of restenosis within the treated vessel. In particular, stent balloon angioplasty of peripheral vessels has yet to achieve patency rates that approximate conventional treatment in the long term.
Anton N. Sidawy+2 more
openaire +3 more sources
Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapy. [PDF]
PurposeRadiation dose escalation for prostate cancer improves biochemical control but is limited by toxicity. Magnetic resonance spectroscopic imaging (MRSI) can define dominant intraprostatic lesions (DIL).
Braunstein, Steve E+9 more
core
Abstract Purpose To investigate the feasibility of adapting a commercial prostate biopsy system for transrectal ultrasound (TRUS)‐guided hybrid gynecological (GYN) high‐dose‐rate (HDR) brachytherapy (BT). Leveraging 3D‐TRUS and MR image fusion, the prototype system aims to improve real‐time needle placement accuracy.
Lindsey H. Bloom+8 more
wiley +1 more source
Energy dependence of the GAFCHROMIC LD‐V1 in the diagnostic radiographic modalities
Abstract The GAFCHROMIC LD‐V1 radiochromic film is widely used in dosimetry because it can provide high‐resolution two‐dimensional dose distributions without processing. This study aimed to evaluate the response characteristics at different effective energies, from the low‐energy range of mammography to the high‐energy range of computed tomography. Net
Tatsuhiro Gotanda+9 more
wiley +1 more source
Use of ultrasound in image-guided high-dose-rate brachytherapy: enumerations and arguments
Inherently, brachytherapy is the most conformal radiotherapeutic technique. As an aid to brachytherapy, ultrasonography (USG) serves as a portable, inexpensive, and simple to use method allowing for accurate, reproducible, and adaptive treatments.
Susovan Banerjee+6 more
doaj +1 more source